Ranolazine Hydrochloride

Known as: Ranolazine Dihydrochloride, Ranolazine HCl, HCl, Ranolazine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2017
01220102017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Ventricular tachycardia/fibrillation (VT/VF) associated with acute myocardial ischemia is the most common cause of… (More)
Is this relevant?
2015
2015
  • Khedkar A. N
  • 2015
A novel stability indicating high performance thin layer chromatography HPTLC assay method was developed and validated for… (More)
  • figure 1
  • table 1
  • table 3
  • table 5
  • table 6
Is this relevant?
2014
2014
BACKGROUND There is a critical need for safer and more effective pharmacological management of atrial fibrillation (AF) in the… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Ranolazine is clinically approved for treatment of angina pectoris and is a potential candidate for antiarrhythmic, antiepileptic… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
  • Acharya Prafulla Chandra
  • 2012
The present paper deals with the development of stability indicating reversed phase high-performance liquid chromatographic (RP… (More)
  • figure 1
  • figure 4
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2012
Review
2012
INTRODUCTION Ranolazine is a novel antianginal and anti-ischemic agent, that, unlike other available antianginal drugs in the… (More)
Is this relevant?
2010
2010
Ranolazine hydrochloride sustained-release tablet (RH-ST) was prepared and its release behavior in vitro was studied. The… (More)
Is this relevant?